Pharma Committee

AMCHAM shared a note on regulatory data protection in the pharmaceutical sector to Mr. Darpan Jain, Additional Secretary, Ministry of Commerce, Government of India. The submission outlined that a well-designed regulatory data protection framework would significantly strengthen India’s pharmaceutical and life sciences ecosystem by encouraging greater R&D investment, expanding clinical research, supporting global capability centers […]

AMCHAM submitted suggestions to the Ministry of Power, Government of India on the Draft National Electricity Policy (NEP), 2026. The suggestions focus upon how India’s electricity transition must be anchored on three inseparable system objectives: reliability of supply, affordability of electricity, and progressive decarbonization. Specific recommendations on resource adequacy and reliability, renewable energy integration, generation

These recommendations were submitted by AmCham Pharma Committee to Drugs Controller General India (DCGI) on 26th April 2016.